SCHEMBL1781414

SCHEMBL1781414

O=C(O)NCc1oc2ccc(Br)cc2c(=O)c1-c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRP O00591 3/20 0.46
▸ GABRD O14764 3/20 0.46
▸ GABRA1 P14867 3/20 0.46
▸ GABRB1 P18505 3/20 0.46
▸ GABRG2 P18507 3/20 0.46
▸ GABRB3 P28472 3/20 0.46
▸ GABRA5 P31644 3/20 0.46
▸ GABRA3 P34903 3/20 0.46
▸ GABRA2 P47869 3/20 0.46
▸ GABRB2 P47870 3/20 0.46
▸ GABRA4 P48169 3/20 0.46
▸ GABRE P78334 3/20 0.46
▸ GABRA6 Q16445 3/20 0.46
▸ GABRG1 Q8N1C3 3/20 0.46
▸ GABRG3 Q99928 3/20 0.46
▸ GABRQ Q9UN88 3/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.45
▸ MAPT P10636 8/20 0.43
▸ NPC1 O15118 3/20 0.42
▸ RAB9A P51151 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8257 0.82 GABRP (0.52) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL8599 0.81 GABRP (0.51) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL8459 0.81 GABRP (0.51) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL30694901 0.81 GABRP (0.51) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL8656 0.79 GABRP (0.49) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL9138 0.79 GABRP (0.49) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL11223 0.77 IDO1 (0.44) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL8860 0.77 KDM4E (0.58) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL11634 0.77 GABRP (0.42) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL8381 0.74 ALDH1A1 (0.57) GABRPGABRDGABRA1GABRB1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110118257-A1 NOVEL KINASE MODULATORS RHIZEN PHARMACEUTICALS SA (CH) 2011-05-19 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118257-A1 NOVEL KINASE MODULATORS PRKCA, PRKCH, PRKCB GABRP 1342/4885GABRD 2739/4885GABRA1 3106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback